Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate

Mostrar otras versiones (1)

Vaccine efforts to combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for the current coronavirus disease 2019 (COVID-19) pandemic, are focused on SARS-CoV-2 spike glycoprotein, the primary target for neutralizing antibodies. We performed cryo–election micr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bangaru, Sandhya, Ozorowski, Gabriel, Turner, Hannah L., Antanasijevic, Aleksandar, Huang, Deli, Wang, Xiaoning, Torres, Jonathan L., Diedrich, Jolene K., Tian, Jing-Hui, Portnoff, Alyse D., Patel, Nita, Massare, Michael J., Yates, John R., Nemazee, David, Paulson, James C., Glenn, Greg, Smith, Gale, Ward, Andrew B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857404/
https://www.ncbi.nlm.nih.gov/pubmed/33082295
http://dx.doi.org/10.1126/science.abe1502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857404/
https://www.ncbi.nlm.nih.gov/pubmed/33082295
http://dx.doi.org/10.1126/science.abe1502

Ejemplares similares